Literature DB >> 9328823

Insulin-like growth factor I inhibits the transcription of collagenase 3 in osteoblast cultures.

S Rydziel1, A M Delany, E Canalis.   

Abstract

Insulin-like growth factor (IGF) I is an autocrine regulator of bone remodeling which inhibits bone collagen degradation and interstitial collagenase 3 mRNA levels. The mechanism of this inhibitory effect on collagenase 3 expression is not known. We tested the effects of IGF I on collagenase 3 gene expression in cultures of osteoblast-enriched cells from 22 day fetal rat calvariae (Ob cells) to determine whether transcriptional or posttranscriptional mechanisms were involved in the regulation of the collagenase 3 gene. IGF I at 10-100 nM caused a dose-dependent decrease in collagenase mRNA and protein levels. IGF I did not modify the half-life of collagenase 3 mRNA in transcriptionally arrested Ob cells, whereas it decreased the levels of interstitial collagenase 3 heterogeneous nuclear RNA. In addition, IGF I decreased the rates of transcription of the collagenase gene and the activity of a 2.1 kilobase collagenase 3 promoter construct transiently transfected into Ob cells. In conclusion, IGF I decreases the expression of collagenase 3 mRNA by transcriptional mechanisms.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328823

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  10 in total

1.  Osteoblast-restricted Disruption of the Growth Hormone Receptor in Mice Results in Sexually Dimorphic Skeletal Phenotypes.

Authors:  Vandana Singhal; Brian C Goh; Mary L Bouxsein; Marie-Claude Faugere; Douglas J DiGirolamo
Journal:  Bone Res       Date:  2013-03-29       Impact factor: 13.567

Review 2.  Targeting subchondral bone for treating osteoarthritis: what is the evidence?

Authors:  Steeve Kwan Tat; Daniel Lajeunesse; Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Best Pract Res Clin Rheumatol       Date:  2010-02       Impact factor: 4.098

3.  Insulin-like growth factor 1 blocks collagen release and down regulates matrix metalloproteinase-1, -3, -8, and -13 mRNA expression in bovine nasal cartilage stimulated with oncostatin M in combination with interleukin 1alpha.

Authors:  W Hui; A D Rowan; T Cawston
Journal:  Ann Rheum Dis       Date:  2001-03       Impact factor: 19.103

4.  Selective Distal Enhancer Control of the Mmp13 Gene Identified through Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) Genomic Deletions.

Authors:  Mark B Meyer; Nancy A Benkusky; J Wesley Pike
Journal:  J Biol Chem       Date:  2015-03-15       Impact factor: 5.157

5.  Deletion of IGF-I receptor (IGF-IR) in primary osteoblasts reduces GH-induced STAT5 signaling.

Authors:  Yujun Gan; Yue Zhang; Douglas J Digirolamo; Jing Jiang; Xiangdong Wang; Xuemei Cao; Kurt R Zinn; David P Carbone; Thomas L Clemens; Stuart J Frank
Journal:  Mol Endocrinol       Date:  2010-02-04

6.  Selective regulation of Mmp13 by 1,25(OH)2D3, PTH, and Osterix through distal enhancers.

Authors:  Mark B Meyer; Nancy A Benkusky; Melda Onal; J Wesley Pike
Journal:  J Steroid Biochem Mol Biol       Date:  2015-09-05       Impact factor: 4.292

7.  Serum IGF-1 affects skeletal acquisition in a temporal and compartment-specific manner.

Authors:  Hayden-William Courtland; Sebastien Elis; Yingjie Wu; Hui Sun; Clifford J Rosen; Karl J Jepsen; Shoshana Yakar
Journal:  PLoS One       Date:  2011-03-18       Impact factor: 3.240

8.  Gene expression analysis in human osteoblasts exposed to dexamethasone identifies altered developmental pathways as putative drivers of osteoporosis.

Authors:  Conor J Hurson; Joseph S Butler; Dominic T Keating; David W Murray; Denise M Sadlier; John M O'Byrne; Peter P Doran
Journal:  BMC Musculoskelet Disord       Date:  2007-02-12       Impact factor: 2.362

Review 9.  Stress and Alterations in Bones: An Interdisciplinary Perspective.

Authors:  Pia-Maria Wippert; Michael Rector; Gisela Kuhn; Karin Wuertz-Kozak
Journal:  Front Endocrinol (Lausanne)       Date:  2017-05-01       Impact factor: 5.555

10.  Modeling osteoporosis to design and optimize pharmacological therapies comprising multiple drug types.

Authors:  David J Jörg; Doris H Fuertinger; Alhaji Cherif; David A Bushinsky; Ariella Mermelstein; Jochen G Raimann; Peter Kotanko
Journal:  Elife       Date:  2022-08-09       Impact factor: 8.713

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.